Literature DB >> 6498035

Pulmonary vascular structure in patients dying after a Fontan procedure. The lung as a risk factor.

E Juaneda, S G Haworth.   

Abstract

Pulmonary vascular structure was analysed in the lungs of 12 patients who had had a Fontan repair, 11 of whom died. Of the eight patients with a low pulmonary blood flow preoperatively, pulmonary vascular structure was almost normal in seven, but in the remaining patient many intra-acinar arteries contained organised occlusive thrombi. Of the four patients with an increased pulmonary blood flow immediately before operation, there was a significant increase in pulmonary vascular smooth muscle despite three of the patients having had a pulmonary arterial band. The findings suggest that it is more difficult for patients with an increased pulmonary blood flow to fulfil the Fontan criteria for repair, and even when the pulmonary vascular resistance is less than 4 units/m2 there may be significant pulmonary vascular abnormalities likely to increase right atrial afterload and prejudice the outcome of a Fontan repair.

Entities:  

Mesh:

Year:  1984        PMID: 6498035      PMCID: PMC481683          DOI: 10.1136/hrt.52.5.575

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  The aetiology of pulmonary thrombosis in cyanotic congenital heart disease with pulmonary stenosis.

Authors:  D HEATH; J W DUSHANE; E H WOOD; J E EDWARDS
Journal:  Thorax       Date:  1958-09       Impact factor: 9.139

2.  Tricuspid atresia. A re-evaluation and classification.

Authors:  R Tandon; J E Edwards
Journal:  J Thorac Cardiovasc Surg       Date:  1974-04       Impact factor: 5.209

3.  Pulmonary arterial development during childhood: branching pattern and structure.

Authors:  A Hislop; L Reid
Journal:  Thorax       Date:  1973-03       Impact factor: 9.139

4.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

5.  New pathological findings in emphysema of childhood. 1. Polyalveolar lobe with emphysema.

Authors:  A Hislop; L Reid
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

6.  Right atrial-right ventricular anastomosis for correction of tricuspid atresia.

Authors:  V O Björk; C L Olin; B B Bjarke; C A Thorén
Journal:  J Thorac Cardiovasc Surg       Date:  1979-03       Impact factor: 5.209

7.  Modified Fontan operation for univentricular heart and complicated congenital lesions.

Authors:  A W Gale; G K Danielson; D C McGoon; D D Mair
Journal:  J Thorac Cardiovasc Surg       Date:  1979-12       Impact factor: 5.209

8.  Fontan procedure for tricuspid atresia.

Authors:  A W Gale; G K Danielson; D C McGoon; R B Wallace; D D Mair
Journal:  Circulation       Date:  1980-07       Impact factor: 29.690

9.  Use of a subpulmonary ventricular chamber in the Fontan circulation.

Authors:  C Bull; M R de Leval; J Stark; J F Taylor; F J Macartney
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

10.  Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue.

Authors:  M Rabinovitch; S G Haworth; Z Vance; G Vawter; A R Castaneda; A S Nadas; L M Reid
Journal:  Hum Pathol       Date:  1980-09       Impact factor: 3.466

View more
  4 in total

Review 1.  Pulmonary hypertension in children: perioperative management.

Authors:  F A Burrows; J R Klinck; M Rabinovitch; D J Bohn
Journal:  Can Anaesth Soc J       Date:  1986-09

2.  Staged septation of double inlet left ventricle.

Authors:  R McKay; R M Bini; J P Wright
Journal:  Br Heart J       Date:  1986-12

3.  Early and late arrhythmias after the Fontan operation: predisposing factors and clinical consequences.

Authors:  M Gewillig; R K Wyse; M R de Leval; J E Deanfield
Journal:  Br Heart J       Date:  1992-01

4.  Pulmonary arterial changes in patients dying after a modified Fontan procedure following pulmonary artery banding.

Authors:  S Yamaki; H Ajiki; K Haneda; Y Takanashi; T Ban; T Takahashi
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.